Purchase Order 75N93025P00903
Award Date
4/14/25
Potential Completion Date
4/13/26
Potential Value
$48K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases (HHS-NIH-NIAID) awarded a $48,209 firm fixed price purchase order to Illumina, Inc. to provide two Nextseq 2000 Silver Support Plans. The solicitation sought comparable services to support NIAID's genomic research efforts, including full parts, labor, and travel coverage; reagent replacement for hardware failures; remote and on-site technical support; software and...
This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc. for a renewal service agreement to support two Illumina NextSeq sequencing systems. The contract has a ceiling value of $74,756.41 and a period of performance through March 20, 2026. There is no set-aside designation for this award. Illumina is a manufacturer of genomic sequencing...
This is a $41,061.69 firm fixed-price purchase order awarded to Illumina, Inc. by the National Institute of Allergy and Infectious Diseases (NIAID) for a NEXTSEQ 500 and MISEQ service agreement. The contract has a period of performance through February 27, 2025. Illumina is a manufacturer of genetic sequencing instruments and reagents that has previously provided similar products and services to support genomic research and diagnostics across various federal agencies. This award does not...
This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Illumina, Inc. for a NextSeq 2000 Silver Support Plan and Preventive Maintenance with a total ceiling value of $23,717.81. The award does not utilize any set-aside designations. Illumina is a manufacturer and provider of sequencing and array-based solutions for genetic and genomic analysis, and has received prior prime federal contract and sub-grant...
This is a firm fixed price purchase order awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Illumina, Inc. for a service agreement renewal and co-term for a NextSeq 2000 Silver Support Plan. The potential value of the award is $29,158.67, and the period of performance runs through July 4, 2024. Illumina is a for-profit manufacturer that has previously provided a range of sequencing systems, reagents, and support services to federal...
This is a $16,127.00 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc. for a service agreement to maintain a MiSeq sequencing instrument. The award does not include any set-aside provisions. Illumina is a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The company has previously received other prime and subcontract awards...
This is a $189,332.15 firm fixed price purchase order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis instruments and reagents. The contract provides an annual service agreement for four Illumina sequencing instruments, including preventative maintenance, parts, labor, reagent replacement, and technical...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc. The $93,525.44 contract provides a 12-month silver support plan for two NextSeq 2000 sequencing systems. No set-aside was used. Illumina is a manufacturer and provider of genomic analysis instruments and reagents, and has previously received prime federal contracts and sub-awards from the NIH, CDC,...
This firm fixed price purchase order was awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Illumina, Inc. for approximately $140,000. The contract is for service agreements to provide preventative maintenance, technical support, software and hardware updates for multiple Illumina DNA sequencers located at the NIH Vaccine Research Center in Bethesda, Maryland, over a one year period of performance from...
The Department of Health and Human Services, National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of sequencing and genomic analysis equipment, for a maintenance/service agreement on three NextSeq 550 and two MiSeq sequencing systems. The $164,807.64 contract has a completion date of February 29, 2024 and will provide priority response for maintenance and repairs on this...